This is Neuren's PH2 TBI results Press Release
Disclosure – NEU.AX is a very small AU/NZ biopharma company that carries substantial risk. While its potential returns may be high its losses may also be high.
I am long NEU.AX.
I do not short stocks.
Wednesday, April 27, 2016
My Neuren Pharma valuation model after their negative PH2 TBI results
This is Neuren's PH2 TBI results Press Release
Disclosure – NEU.AX is a very small AU/NZ biopharma company that carries substantial risk. While its potential returns may be high its losses may also be high.
I am long NEU.AX.
I do not short stocks.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment